Jill Feldman: Thank you Mara Antonoff for truly being patient-centered
Jill Feldman shared a post by Jonathan Spicer, Associate Professor of Surgery at McGill University, on X/Twitter:
“YES! There are challenges of operating after induction surgery, but ‘if it’s best for the patient, we should become better surgeons’ Thank you Mara Antonoff for truly being patient-centered and for your true north being, what’s best for the patient.”
Quoting Jonathan Spicer’s post:
“Mara Antonoff lighting up the room with the challenges of operating after induction but she argues if that’s the best for the patient, we should become better surgeons and get it done for our patients!”
Source: Jill Feldman/X and Jonathan Spicer/X
Jill Feldman is a lung cancer patient and advocate. She is the Co-Founder EGFR Resisters, an advocacy group of EGFR positive lung cancer patients who are resistant to targeted treatment. She is the Past President of the LUNGevity Foundation, Deputy Chair of IASLC’s patient advisory board and a member of The Chicago Institute of Translational Medicine’s patient advisory board.
Jill is committed to understanding and promoting patient-centered research as a member of the programmatic panel for the Department of Defense Lung Cancer Research Program, as a planning committee member on IASLC’s North America Conference on Lung cancer and as a member of the the ECOG-ACRIN Research Group’s patient advocate committee and thoracic committee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023